Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection...
Leadership
D. Lynn Kirkpatrick Ph.D.
President, CEO & Director
David C. Humphrey CPA
CFO, Secretary & Treasurer
Geoffrey Birkett
Chief Commercial Officer
Jeffrey Millard Ph.d.
Chief Operating Officer
William K. Schmidt Ph.D.
Chairman of Clinical Advisory Board & Chief Medical Officer
